GlassScriptPhysician profile
Matthew David Truscello
NPI 1437397007
$4,594.51
in general payments reported to CMS, 2019-2025
42 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $338 · 2021: $673 · 2022: $1,100 · 2023: $859 · 2024: $361 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $556.82 | 2019-2023 | Puraply |
| Orthofix Medical, INC. | $547.62 | 2019-2025 | Physio-Stim |
| Stryker Corporation | $535.11 | 2019-2023 | Spy-Phi System, Augment Injectable |
| Rikco International, LLC | $432.44 | 2019-2021 | |
| Kerecis Limited | $372.96 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $263.55 | 2019-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $218.14 | 2020-2025 | Nuzyra |
| Grt US Holding, INC. | $179.21 | 2022 | |
| Averitas Pharma INC. | $141.57 | 2023-2025 | Qutenza |
| Medtronic, INC. | $118.68 | 2022-2023 | Intellis Adaptivestim |
| Djo, LLC | $104.86 | 2023-2025 | Cmf |
| Treace Medical Concepts, INC. | $98.08 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $82.18 | 2019-2021 | |
| Abbott Laboratories | $77.58 | 2019-2024 | Proclaim |
| Horizon Therapeutics Plc | $69.06 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $67.13 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Crossroads Extremity Systems, LLC | $65.67 | 2019-2021 | |
| Alpha Orthopedic Systems | $51.93 | 2021 | |
| Sanara Medtech INC. | $48.90 | 2021-2023 | Celleraterx |
| Triad Life Sciences INC. | $46.15 | 2021-2022 | |
| Nevro Corp. | $45.18 | 2022-2023 | Senza |
| Depuy Synthes Sales INC. | $44.91 | 2021-2025 | Motoband |
| Paragon 28, INC. | $34.83 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $33.19 | 2025 | |
| Bioventus LLC | $32.30 | 2024 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $30.75 | 2021 | |
| Merck Sharp & Dohme LLC | $30.47 | 2019 | |
| Melinta Therapeutics, LLC | $29.58 | 2019-2020 | |
| Allergan, INC. | $29.16 | 2020 | |
| Nabriva Therapeutics, Plc | $29.16 | 2021-2022 | |
| Progenacare Global, LLC | $25.60 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $18.40 | 2019 | |
| Arteriocyte Medical Systems, INC. | $17.20 | 2020 | |
| Arthrosurface Incorporated | $15.41 | 2020 | |
| Acera Surgical, INC. | $14.23 | 2025 | Restrata Wound Matrix |
| Solventum Corporation | $13.95 | 2025 | V.A.C.Instill |
| Abbvie INC. | $13.33 | 2022 | |
| Wright Medical Technology, INC. | $12.95 | 2019 | |
| Wound Management Technologies, INC | $12.92 | 2019 | |
| Aroa Biosurgery Incorporated | $12.50 | 2020 | |
| Advanced Oxygen Therapy INC. | $10.90 | 2024 | Topical Oxygen Chamber For Extremities |
| Polarityte, INC. | $9.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Truscello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.